Naloxone Hydrochloride Injection, Solution
Product Images NDC 0409-1219

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 0409-1219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Naloxone Hydrochloride (Naloxone 01)

Chemical structure of Naloxone Hydrochloride, showing the molecular arrangement including hydroxyl groups, double bonds, and the hydrochloride component as part of the compound.*

FDA Label Image

Logo (Naloxone 02)

FDA Label Image

Principal Display Panel (1 mL Vial Label)

Naloxone Hydrochloride Injection, USP 0.4 mg/mL, 1 mL single-dose solution for intramuscular, intravenous, or subcutaneous use. The label displays the proprietary name Naloxone HCI prominently in orange, specifies protection from light and prescription use, and lists Hospira, Inc. as the distributor in Lake Forest, IL, USA. Includes NDC 0409-1215-21 and batch/lot number details.*

FDA Label Image

Principal Display Panel (1 mL Vial Carton)

The image shows a flattened carton label for Naloxone Hydrochloride Injection, USP, 0.4 mg/mL in a 1 mL single-dose Fliptop vial. The label indicates the product is for injection and is manufactured by Hospira, Inc. It includes storage instructions to protect from light and store at 20 to 25°C. The label displays barcode images and mentions the necessity of aseptic technique for use via intravenous, intramuscular, or subcutaneous routes.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Naloxone Hydrochloride injection, USP, 4 mg per 10 mL (0.4 mg/mL) multiple-dose vial. It is for intravenous, intramuscular, or subcutaneous use and distributed by Hospira, Inc. The label includes storage instructions, dosage form, route of administration, and NDC 0409-1219-41.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Packaging label for Naloxone Hydrochloride Injection, USP 4 mg/10 mL (0.4 mg/mL) in a 10 mL multiple-dose fliptop vial. The label indicates sterile, nonpyrogenic solution for intravenous, intramuscular, or subcutaneous use. Distributed by Hospira, Inc., it includes storage instructions and lists preservatives methylparaben and propylparaben, with sodium chloride for tonicity adjustment.*

FDA Label Image

Principal Display Panel (1 mL Ampul Label)

Naloxone Hydrochloride Injection, USP 0.4 mg/mL in a 1 mL presentation by Hospira, Inc. The label indicates protection from light and specifies use for intravenous, intramuscular, and subcutaneous administration. The product is marked Rx only with NDC 0409-1212-01.*

FDA Label Image

Principal Display Panel (1 mL Ampul Tray)

Naloxone Hydrochloride Injection, USP 0.4 mg/mL label for a 1 mL ampul. The label indicates it is for intramuscular, intravenous, or subcutaneous use. It includes storage instructions, sodium chloride for tonicity adjustment, and a pH of 4.0. The label shows the Hospira, Inc. brand and the NDC 0409-1212-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.